Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 355

1.

Sporadic Angiomyolipomas (AMLs) Growth Kinetics While on Everolimus (SAGE): Results of a Phase II Trial.

Geynisman DM, Kadow BT, Shuch BM, Boorjian SA, Matin SF, Rampersaud E, Milestone BN, Plimack ER, Zibelman MR, Kutikov A, Smaldone MC, Chen DY, Viterbo R, Joshi S, Greenberg RE, Malizzia L, McGowan T, Ross EA, Uzzo RG.

J Urol. 2020 Apr 6:101097JU0000000000001065. doi: 10.1097/JU.0000000000001065. [Epub ahead of print]

PMID:
32250730
2.

Robotic Partial Nephrectomy versus Minimally Invasive Radical Nephrectomy for Clinical T2a Renal Mass: A Propensity Score Matched Comparison from the ROSULA (Robotic Surgery for Large Renal Mass) Collaborative Group.

Bradshaw AW, Autorino R, Simone G, Yang B, Uzzo RG, Porpiglia F, Capitanio U, Porter J, Bertolo R, Minervini A, Lau C, Jacobsohn K, Ashrafi A, Eun D, Mottrie A, White WM, Schips L, Challacombe BJ, De Cobelli O, Mir CM, Veccia A, Larcher A, Kutikov A, Aron M, Dasgupta P, Montorsi F, Gill IS, Sundaram CP, Kaouk J, Derweesh IH.

BJU Int. 2020 Mar 31. doi: 10.1111/bju.15064. [Epub ahead of print]

PMID:
32232920
3.

A War on Two Fronts: Cancer Care in the Time of COVID-19.

Kutikov A, Weinberg DS, Edelman MJ, Horwitz EM, Uzzo RG, Fisher RI.

Ann Intern Med. 2020 Mar 27. doi: 10.7326/M20-1133. [Epub ahead of print] No abstract available.

PMID:
32219410
4.

Ten-Year Update of a Randomized, Prospective Trial of Conventional Fractionated Versus Moderate Hypofractionated Radiation Therapy for Localized Prostate Cancer.

Avkshtol V, Ruth KJ, Ross EA, Hallman MA, Greenberg RE, Price RA Jr, Leachman B, Uzzo RG, Ma C, Chen D, Geynisman DM, Sobczak ML, Zhang E, Wong JK, Pollack A, Horwitz EM.

J Clin Oncol. 2020 Mar 2:JCO1901485. doi: 10.1200/JCO.19.01485. [Epub ahead of print]

PMID:
32119599
5.

Overall tumor genomic instability: an important predictor of recurrence-free survival in patients with localized clear cell renal cell carcinoma.

Correa AF, Ruth KJ, Al-Saleem T, Pei J, Dulaimi E, Kister D, Collins M, Abbosh PH, Slifker MJ, Ross E, Uzzo RG, Testa JR.

Cancer Biol Ther. 2020 May 3;21(5):424-431. doi: 10.1080/15384047.2020.1721251. Epub 2020 Mar 1.

PMID:
32116106
6.

Application of Chromosome Microarray Analysis for the Differential Diagnosis of Low-grade Renal Cell Carcinoma With Clear Cell and Papillary Features.

Pei J, Al-Saleem T, Uzzo RG, Dulaimi E, Testa JR, Wei S.

Appl Immunohistochem Mol Morphol. 2020 Feb;28(2):123-129. doi: 10.1097/PAI.0000000000000704.

PMID:
32044880
7.

Results of the ADAPT phase 3 study of Rocapuldencel-T in combination with sunitinib as first-line therapy in patients with metastatic renal cell carcinoma.

Figlin RA, Tannir NM, Uzzo RG, Tykodi SS, Chen DYT, Master V, Kapoor A, Vaena D, Lowrance WT, Bratslavsky G, DeBenedette M, Gamble A, Plachco A, Norris MS, Horvatinovich J, Tcherepanova IY, Nicolette CA, Wood CG.

Clin Cancer Res. 2020 Feb 7. pii: clincanres.2427.2019. doi: 10.1158/1078-0432.CCR-19-2427. [Epub ahead of print]

PMID:
32034074
8.

The volume-outcome relationship in kidney cancer: is more really better?

Kadow BT, Joshi SS, Kutikov A, Handorf E, Smaldone MC, Uzzo RG, Geynisman DM.

Ann Transl Med. 2019 Dec;7(Suppl 8):S336. doi: 10.21037/atm.2019.09.108. No abstract available.

9.

Clinical Cancer Advances 2020: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology.

Markham MJ, Wachter K, Agarwal N, Bertagnolli MM, Chang SM, Dale W, Diefenbach CSM, Rodriguez-Galindo C, George DJ, Gilligan TD, Harvey RD, Johnson ML, Kimple RJ, Knoll MA, LoConte N, Maki RG, Meisel JL, Meyerhardt JA, Pennell NA, Rocque GB, Sabel MS, Schilsky RL, Schneider BJ, Tap WD, Uzzo RG, Westin SN.

J Clin Oncol. 2020 Apr 1;38(10):1081. doi: 10.1200/JCO.19.03141. Epub 2020 Feb 4.

PMID:
32013670
10.

Effect of Obesity and Overweight Status on Complications and Survival After Minimally Invasive Kidney Surgery in Patients with Clinical T2-4 Renal Masses.

Marchioni M, Berardinelli F, Zhang C, Simone G, Uzzo RG, Capitanio U, Minervini A, Lau C, Kaouk J, Langenstroer P, Amparore D, de Luyk N, Porter J, Gallucci M, Kutikov A, Larcher A, Mari A, Kilday P, Rha KH, Quarto G, Perdonà S, White W, Eun DD, Derweesh I, Mottrie A, Anele UA, Jacobsohn K, Porpiglia F, Challacombe B, Sundaram CP, Autorino R, Yang B, Schips L.

J Endourol. 2020 Mar;34(3):289-297. doi: 10.1089/end.2019.0604.

PMID:
31950886
11.

PBRM1 acts as a p53 lysine-acetylation reader to suppress renal tumor growth.

Cai W, Su L, Liao L, Liu ZZ, Langbein L, Dulaimi E, Testa JR, Uzzo RG, Zhong Z, Jiang W, Yan Q, Zhang Q, Yang H.

Nat Commun. 2019 Dec 20;10(1):5800. doi: 10.1038/s41467-019-13608-1.

12.

Predictive Value of Nephrometry Scores in Nephron-sparing Surgery: A Systematic Review and Meta-analysis.

Veccia A, Antonelli A, Uzzo RG, Novara G, Kutikov A, Ficarra V, Simeone C, Mirone V, Hampton LJ, Derweesh I, Porpiglia F, Autorino R.

Eur Urol Focus. 2019 Nov 24. pii: S2405-4569(19)30345-1. doi: 10.1016/j.euf.2019.11.004. [Epub ahead of print] Review.

PMID:
31776071
13.

Reply by Authors.

Minervini A, Campi R, Lane BR, De Cobelli O, Sanguedolce F, Hatzichristodoulou G, Antonelli A, Noyes S, Mari A, Rodriguez-Faba O, Keeley FX, Langenhuijsen J, Musi G, Klatte T, Roscigno M, Akdogan B, Furlan M, Karakoyunlu N, Marszalek M, Capitanio U, Volpe A, Brookman-May S, Gschwend JE, Smaldone MC, Uzzo RG, Carini M, Kutikov A.

J Urol. 2020 Mar;203(3):503-504. doi: 10.1097/JU.0000000000000591.02. Epub 2019 Nov 27. No abstract available.

PMID:
31774733
14.

Monosomy of Chromosome 9 Is Associated With Higher Grade, Advanced Stage, and Adverse Outcome in Clear-cell Renal Cell Carcinoma.

Nejati R, Wei S, Uzzo RG, Poureghbali S, Pei J, Talarchek JN, Ruth K, Dulaimi E, Kutikov A, Testa JR, Al-Saleem T.

Clin Genitourin Cancer. 2020 Feb;18(1):56-61. doi: 10.1016/j.clgc.2019.09.016. Epub 2019 Sep 26.

PMID:
31648964
15.

Non-contrast imaging characteristics of papillary renal cell carcinoma: implications for diagnosis and subtyping.

Badri AV, Waingankar N, Edwards K, Kutikov A, Parsons RB, Chen DY, Smaldone MC, Viterbo R, Greenberg RE, Uzzo RG.

Can J Urol. 2019 Oct;26(5):9916-9921.

PMID:
31629440
16.

Impact of Resection Technique on Perioperative Outcomes and Surgical Margins after Partial Nephrectomy for Localized Renal Masses: A Prospective Multicenter Study.

Minervini A, Campi R, Lane BR, De Cobelli O, Sanguedolce F, Hatzichristodoulou G, Antonelli A, Noyes S, Mari A, Rodriguez-Faba O, Keeley FX, Langenhuijsen J, Musi G, Klatte T, Roscigno M, Akdogan B, Furlan M, Karakoyunlu N, Marszalek M, Capitanio U, Volpe A, Brookman-May S, Gschwend JE, Smaldone MC, Uzzo RG, Carini M, Kutikov A.

J Urol. 2020 Mar;203(3):496-504. doi: 10.1097/JU.0000000000000591. Epub 2019 Oct 14.

PMID:
31609167
17.

Local Recurrence Following Resection of Intermediate-High Risk Nonmetastatic Renal Cell Carcinoma: An Anatomical Classification and Analysis of the ASSURE (ECOG-ACRIN E2805) Adjuvant Trial.

Lee Z, Jegede OA, Haas NB, Pins MR, Messing EM, Manola J, Wood CG, Kane CJ, Jewett MAS, Flaherty KT, Dutcher JP, DiPaola RS, Uzzo RG.

J Urol. 2020 Apr;203(4):684-689. doi: 10.1097/JU.0000000000000588. Epub 2019 Oct 9.

PMID:
31596672
18.

Angiogenic Factor and Cytokine Analysis among Patients Treated with Adjuvant VEGFR TKIs in Resected Renal Cell Carcinoma.

Xu W, Puligandla M, Manola J, Bullock AJ, Tamasauskas D, McDermott DF, Atkins MB, Haas NB, Flaherty K, Uzzo RG, Dutcher JP, DiPaola RS, Bhatt RS.

Clin Cancer Res. 2019 Oct 15;25(20):6098-6106. doi: 10.1158/1078-0432.CCR-19-0818. Epub 2019 Aug 30.

PMID:
31471309
19.

Treatment Facility Volume and Survival in Patients with Advanced Prostate Cancer.

Joshi SS, Handorf ER, Sienko D, Zibelman M, Uzzo RG, Kutikov A, Horwitz EM, Smaldone MC, Geynisman DM.

Eur Urol Oncol. 2020 Feb;3(1):104-111. doi: 10.1016/j.euo.2019.06.016. Epub 2019 Jul 18.

PMID:
31326500
20.

Trends in Regionalization of Care and Mortality For Patients Treated With Radical Cystectomy.

Waingankar N, Mallin K, Egleston BL, Winchester DP, Uzzo RG, Kutikov A, Smaldone MC.

Med Care. 2019 Sep;57(9):728-733. doi: 10.1097/MLR.0000000000001143.

PMID:
31313685
21.

Predicting Renal Cancer Recurrence: Defining Limitations of Existing Prognostic Models With Prospective Trial-Based Validation.

Correa AF, Jegede O, Haas NB, Flaherty KT, Pins MR, Messing EM, Manola J, Wood CG, Kane CJ, Jewett MAS, Dutcher JP, DiPaola RS, Carducci MA, Uzzo RG.

J Clin Oncol. 2019 Aug 10;37(23):2062-2071. doi: 10.1200/JCO.19.00107. Epub 2019 Jun 19.

22.

Prediction of significant estimated glomerular filtration rate decline after renal unit removal to aid in the clinical choice between radical and partial nephrectomy in patients with a renal mass and normal renal function.

McIntosh AG, Parker DC, Egleston BL, Uzzo RG, Haseebuddin M, Joshi SS, Viterbo R, Greenberg RE, Chen DYT, Smaldone MC, Kutikov A.

BJU Int. 2019 Dec;124(6):999-1005. doi: 10.1111/bju.14839. Epub 2019 Jun 30.

PMID:
31145523
23.

Reassessing the Role of Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma in 2019.

Psutka SP, Chang SL, Cahn D, Uzzo RG, McGregor BA.

Am Soc Clin Oncol Educ Book. 2019 Jan;39:276-283. doi: 10.1200/EDBK_237453. Epub 2019 May 17. Review.

24.

Editorial Comment.

Joshi SS, Uzzo RG.

Urology. 2019 Feb;124:165-167. doi: 10.1016/j.urology.2018.03.058. No abstract available.

PMID:
30784710
25.

Perioperative Statin Use and Acute Kidney Injury in Patients Undergoing Partial Nephrectomy.

Joshi SS, Ruth K, Smaldone MC, Chen DYT, Greenberg RE, Viterbo R, Kutikov A, Uzzo RG.

Kidney Cancer. 2018 Mar 30;2(1):47-55. doi: 10.3233/KCA-180031.

26.

Robotic versus laparoscopic radical nephrectomy: a large multi-institutional analysis (ROSULA Collaborative Group).

Anele UA, Marchioni M, Yang B, Simone G, Uzzo RG, Lau C, Mir MC, Capitanio U, Porter J, Jacobsohn K, de Luyk N, Mari A, Chang K, Fiori C, Sulek J, Mottrie A, White W, Perdona S, Quarto G, Bindayi A, Ashrafi A, Schips L, Berardinelli F, Zhang C, Gallucci M, Ramirez-Backhaus M, Larcher A, Kilday P, Liao M, Langenstroer P, Dasgupta P, Challacombe B, Kutikov A, Minervini A, Rha KH, Sundaram CP, Hampton LJ, Porpiglia F, Aron M, Derweesh I, Autorino R.

World J Urol. 2019 Nov;37(11):2439-2450. doi: 10.1007/s00345-019-02657-2. Epub 2019 Feb 7.

PMID:
30734072
27.

Active Surveillance as Initial Management of Newly Diagnosed Prostate Cancer: Data from the PURC.

Botejue M, Abbott D, Danella J, Fonshell C, Ginzburg S, Guzzo TJ, Lanchoney T, Marlowe B, Raman JD, Smaldone M, Tomaszewski JJ, Trabulsi EJ, Uzzo RG, Reese AC.

J Urol. 2019 May;201(5):929-936. doi: 10.1016/j.juro.2018.10.018.

PMID:
30720692
28.

A Return to the Days of Radical Nephrectomy as the "Gold Standard" for Localized Renal Cell Carcinoma? Not So Fast.

Derweesh IH, Staehler M, Uzzo RG.

Eur Urol. 2019 Apr;75(4):546-547. doi: 10.1016/j.eururo.2019.01.003. Epub 2019 Jan 14.

PMID:
30655089
29.

NEAT1-TFE3 and KAT6A-TFE3 renal cell carcinomas, new members of MiT family translocation renal cell carcinoma.

Pei J, Cooper H, Flieder DB, Talarchek JN, Al-Saleem T, Uzzo RG, Dulaimi E, Patchefsky AS, Testa JR, Wei S.

Mod Pathol. 2019 May;32(5):710-716. doi: 10.1038/s41379-018-0191-7. Epub 2019 Jan 8.

30.

Author Response.

Correa AF, Uzzo RG.

Urology. 2019 Jan;123:179-180. doi: 10.1016/j.urology.2018.08.046. No abstract available.

PMID:
30598208
31.

Incisional hernia after cystectomy: incidence, risk factors and anthropometric predisposition.

Edwards DC, Cahn DB, Reddy M, Kivlin D, Malhotra A, Li T, Chen DYT, Viterbo R, Uzzo RG, Greenberg RE, Smaldone MC, Curcillo P, Kutikov A.

Can J Urol. 2018 Dec;25(6):9573-9578.

PMID:
30553281
32.

Application of Chromosome Microarray Analysis for the Differential Diagnosis of Low-grade Renal Cell Carcinoma With Clear Cell and Papillary Features.

Pei J, Al-Saleem T, Uzzo RG, Dulaimi E, Testa JR, Wei S.

Appl Immunohistochem Mol Morphol. 2018 Nov 28. doi: 10.1097/PAI.0000000000000704. [Epub ahead of print]

PMID:
30499818
33.

Assessment of volume preservation performed before or after partial nephrectomy accurately predicts postoperative renal function: Results from a prospective multicenter study.

Klingler MJ, Babitz SK, Kutikov A, Campi R, Hatzichristodoulou G, Sanguedolce F, Brookman-May S, Akdogan B, Capitanio U, Roscigno M, Volpe A, Marszalek M, Uzzo RG, Antonelli A, Langenhuijsen J, Carini M, Minervini A, Lane BR.

Urol Oncol. 2019 Jan;37(1):33-39. doi: 10.1016/j.urolonc.2018.11.007. Epub 2018 Nov 23.

PMID:
30473205
34.

Perioperative Therapy in Renal Cell Carcinoma: What Do We Know, What Have We Learned, What's Next?

Haas NB, Uzzo RG.

J Clin Oncol. 2018 Oct 29:JCO2018789131. doi: 10.1200/JCO.2018.78.9131. [Epub ahead of print]

PMID:
30372398
35.

Multiple tumor suppressors regulate a HIF-dependent negative feedback loop via ISGF3 in human clear cell renal cancer.

Liao L, Liu ZZ, Langbein L, Cai W, Cho EA, Na J, Niu X, Jiang W, Zhong Z, Cai WL, Jagannathan G, Dulaimi E, Testa JR, Uzzo RG, Wang Y, Stark GR, Sun J, Peiper S, Xu Y, Yan Q, Yang H.

Elife. 2018 Oct 25;7. pii: e37925. doi: 10.7554/eLife.37925.

36.

Renal Hilar Lesions: Biological Implications for Complex Partial Nephrectomy.

Correa AF, Yankey H, Li T, Joshi SS, Kutikov A, Chen DY, Viterbo R, Greenberg RE, Smaldone MC, Uzzo RG.

Urology. 2019 Jan;123:174-180. doi: 10.1016/j.urology.2018.08.044. Epub 2018 Oct 6.

PMID:
30296503
37.

Does the Surgical Apgar Score predict serious complications after elective major cancer surgery?

Goel N, Manstein SM, Ward WH, DeMora L, Smaldone MC, Farma JM, Uzzo RG, Esnaola NF.

J Surg Res. 2018 Nov;231:242-247. doi: 10.1016/j.jss.2018.05.037. Epub 2018 Jun 23.

PMID:
30278936
38.

Partial nephrectomy is not associated with an overall survival advantage over radical nephrectomy in elderly patients with stage Ib-II renal masses: An analysis of the national cancer data base.

Ristau BT, Handorf EA, Cahn DB, Kutikov A, Uzzo RG, Smaldone MC.

Cancer. 2018 Oct 1;124(19):3839-3848. doi: 10.1002/cncr.31582. Epub 2018 Sep 12.

39.

Resistance to Systemic Therapies in Clear Cell Renal Cell Carcinoma: Mechanisms and Management Strategies.

Makhov P, Joshi S, Ghatalia P, Kutikov A, Uzzo RG, Kolenko VM.

Mol Cancer Ther. 2018 Jul;17(7):1355-1364. doi: 10.1158/1535-7163.MCT-17-1299. Review.

40.

Treatment Facility Volume and Survival in Patients with Metastatic Renal Cell Carcinoma: A Registry-based Analysis.

Joshi SS, Handorf EA, Zibelman M, Plimack ER, Uzzo RG, Kutikov A, Smaldone MC, Geynisman DM.

Eur Urol. 2018 Sep;74(3):387-393. doi: 10.1016/j.eururo.2018.05.025. Epub 2018 Jun 5.

PMID:
29880274
41.

The Temporal Association of Robotic Surgical Diffusion with Overtreatment of the Small Renal Mass.

Shah PH, Alom MA, Leibovich BC, Thompson RH, Uzzo RG, Kavoussi LR, Richstone L, Bhindi B, Habermann EB, Joshi V, Boorjian SA.

J Urol. 2018 Nov;200(5):981-988. doi: 10.1016/j.juro.2018.05.081. Epub 2018 May 22.

PMID:
29792881
42.

Outcomes of Robot-assisted Partial Nephrectomy for Clinical T2 Renal Tumors: A Multicenter Analysis (ROSULA Collaborative Group).

Bertolo R, Autorino R, Simone G, Derweesh I, Garisto JD, Minervini A, Eun D, Perdona S, Porter J, Rha KH, Mottrie A, White WM, Schips L, Yang B, Jacobsohn K, Uzzo RG, Challacombe B, Ferro M, Sulek J, Capitanio U, Anele UA, Tuderti G, Costantini M, Ryan S, Bindayi A, Mari A, Carini M, Keehn A, Quarto G, Liao M, Chang K, Larcher A, De Naeyer G, De Cobelli O, Berardinelli F, Zhang C, Langenstroer P, Kutikov A, Chen D, De Luyk N, Sundaram CP, Montorsi F, Stein RJ, Haber GP, Hampton LJ, Dasgupta P, Gallucci M, Kaouk J, Porpiglia F.

Eur Urol. 2018 Aug;74(2):226-232. doi: 10.1016/j.eururo.2018.05.004. Epub 2018 May 19.

PMID:
29784191
43.

Active Surveillance for Localized Renal Masses: Tumor Growth, Delayed Intervention Rates, and >5-yr Clinical Outcomes.

McIntosh AG, Ristau BT, Ruth K, Jennings R, Ross E, Smaldone MC, Chen DYT, Viterbo R, Greenberg RE, Kutikov A, Uzzo RG.

Eur Urol. 2018 Aug;74(2):157-164. doi: 10.1016/j.eururo.2018.03.011. Epub 2018 Apr 4.

PMID:
29625756
44.

Comparison of functional outcomes of robotic and open partial nephrectomy in patients with pre-existing chronic kidney disease: a multicenter study.

Hamilton ZA, Uzzo RG, Larcher A, Lane BR, Ristau B, Capitanio U, Ryan S, Dey S, Correa A, Reddy M, Proudfoot JA, Nasseri R, Yim K, Noyes S, Bindayi A, Montorsi F, Derweesh IH.

World J Urol. 2018 Aug;36(8):1255-1262. doi: 10.1007/s00345-018-2261-3. Epub 2018 Mar 12.

PMID:
29532222
45.

The convergent roles of NF-κB and ER stress in sunitinib-mediated expression of pro-tumorigenic cytokines and refractory phenotype in renal cell carcinoma.

Makhov P, Naito S, Haifler M, Kutikov A, Boumber Y, Uzzo RG, Kolenko VM.

Cell Death Dis. 2018 Mar 7;9(3):374. doi: 10.1038/s41419-018-0388-1.

46.

Treatment Trends and Outcomes for Patients With Lymph Node-Positive Cancer of the Penis.

Joshi SS, Handorf E, Strauss D, Correa AF, Kutikov A, Chen DYT, Viterbo R, Greenberg RE, Uzzo RG, Smaldone MC, Geynisman DM.

JAMA Oncol. 2018 May 1;4(5):643-649. doi: 10.1001/jamaoncol.2017.5608.

47.

Discrimination of malignant and normal kidney tissue with short wave infrared dispersive Raman spectroscopy.

Haifler M, Pence I, Sun Y, Kutikov A, Uzzo RG, Mahadevan-Jansen A, Patil CA.

J Biophotonics. 2018 Jun;11(6):e201700188. doi: 10.1002/jbio.201700188. Epub 2018 May 16.

PMID:
29411949
48.

The correlation between gain of chromosome 8q and survival in patients with clear and papillary renal cell carcinoma.

Mehrazin R, Dulaimi E, Uzzo RG, Devarjan K, Pei J, Smaldone MC, Kutikov A, Testa JR, Al-Saleem T.

Ther Adv Urol. 2017 Oct 31;10(1):3-10. doi: 10.1177/1756287217732660. eCollection 2018 Jan.

49.

Differences in Survival Associated with Performance of Lymph Node Dissection in Patients with Invasive Penile Cancer: Results from the National Cancer Database.

Correa AF, Handorf E, Joshi SS, Geynisman DM, Kutikov A, Chen DY, Uzzo RG, Viterbo R, Greenberg RE, Smaldone MC.

J Urol. 2018 May;199(5):1238-1244. doi: 10.1016/j.juro.2017.11.121. Epub 2017 Dec 15.

PMID:
29248557
50.

A structured framework for optimizing surgical quality through process-of-care trials.

Waingankar N, Esnaola NF, Uzzo RG.

Urol Oncol. 2017 May;35(5):177-179. doi: 10.1016/j.urolonc.2017.03.017. Epub 2017 Apr 18.

PMID:
29037530

Supplemental Content

Support Center